8-MOP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover 8-mop, and what generic alternatives are available?
8-mop is a drug marketed by Valeant Pharm Intl and is included in one NDA.
The generic ingredient in 8-MOP is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for 8-mop
A generic version of 8-MOP was approved as methoxsalen by STRIDES PHARMA on June 5th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for 8-MOP?
- What are the global sales for 8-MOP?
- What is Average Wholesale Price for 8-MOP?
Summary for 8-MOP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 150 |
| Patent Applications: | 5,016 |
| DailyMed Link: | 8-MOP at DailyMed |
US Patents and Regulatory Information for 8-MOP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharm Intl | 8-MOP | methoxsalen | CAPSULE;ORAL | 009048-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
